BioSpace News Archive

New legislation in Illinois to make insulin more affordable for all Illinoisans who need it

AANA – In honor of National CRNA Week, Reps. Jan Schakowsky, Lucille Roybal-Allard, and Sam Graves today introduced a bipartisan resolution on the House floor, “Recognizing the roles and the contributions of America’s Certified Registered Nurse Anesthetists and their role in providing quality health care for the public.”.

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC, announces that KSF has commenced an investigation into CV Sciences, Inc.

SunGen Pharma announced the U.S. launch and commercial shipment of generic version of Bentyl® Injection, in collaboration with Camber Pharmaceuticals, who will be SunGen’s distribution and marketing partner.

BERG announced the presentation of initial results from a Phase 2 clinical trial at the Gastrointestinal Cancer Symposium, being held in San Francisco from January 23 – 25, 2020.

Greater than 50% enrollment achieved in ongoing Phase 3 trial of eryaspase in pancreatic cancer

First Databank, Inc., the leading provider of drug and medical device knowledge that helps healthcare professionals make precise decisions, announced the appointment of Brian Taylor as vice president of sales.

Beam Therapeutics, a biotechnology company developing precision genetic medicines through base editing, today announced the promotion of chief scientific officer Giuseppe “Pino” Ciaramella, Ph.D., to president.

IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage biopharmaceutical company pioneering a novel class of immunotherapies, today announced that it will host a key opinion leader symposium on the role of survivin in cancer biology and DPX-Survivac’s potential as a targeted immunotherapeutic agent across a range of tumor types.

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating and developing small molecule drugs for viral infections and liver diseases, today announced that it plans to report its financial results for its fiscal first quarter ended December 31, 2019, after the U.S. markets close on February 6, 2020.